Latest & greatest articles for menopause

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on menopause or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on menopause and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for menopause

61. Canadian Consensus on Female Nutrition: Adolescence, Reproduction, Menopause, and Beyond

Canadian Consensus on Female Nutrition: Adolescence, Reproduction, Menopause, and Beyond Canadian Consensus on Female Nutrition: Adolescence, Reproduction, Menopause, and Beyond - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 38, Issue 6, Pages 508–554.e18 To read this article in full, please review your options for gaining access at the bottom of the page. Canadian Consensus on Female Nutrition: Adolescence (...) , Reproduction, Menopause, and Beyond Nutrition Working Group x Deborah L. O'Connor , PhD, RD (Principal Author) Toronto ON x Jennifer Blake , MD (Principal Author) Ottawa ON x Rhonda Bell , PhD (Principal Author) Edmonton AB x Angela Bowen , PhD, RN (Principal Author) Saskatoon SK x Jeannie Callum , MD (Principal Author) Toronto ON x Shanna Fenton , MD (Principal Author) Saskatoon SK x Katherine Gray-Donald , PhD (Principal Author) Montreal QC x Melissa Rossiter , PhD, RD (Principal Author) Charlottetown

2016 Society of Obstetricians and Gynaecologists of Canada

62. Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis (PubMed)

Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis To test the hypothesis that effects of estrogen-containing hormone therapy on cognitive abilities differ between postmenopausal women near to, and further from, menopause.In this randomized, double-blind, placebo-controlled trial, healthy women within 6 years of menopause or 10+ years after menopause were randomly assigned to oral 17β-estradiol 1 mg/d or placebo. Women with a uterus received cyclic (...) in composite scores (-0.06, 95% confidence interval -0.22 to 0.09) was not significant (2-tailed p = 0.33). Differences were similar in early and late postmenopause groups (2-tailed interaction p = 0.88). Interactions between postmenopause groups and differences between treatment groups were not significant for executive functions or global cognition.Estradiol initiated within 6 years of menopause does not affect verbal memory, executive functions, or global cognition differently than therapy begun 10

Full Text available with Trip Pro

2016 EvidenceUpdates

63. Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis. (PubMed)

Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis. Between 40% and 50% of women in Western countries use complementary therapies to manage menopausal symptoms.To determine the association of plant-based therapies with menopausal symptoms, including hot flashes, night sweats, and vaginal dryness.The electronic databases Ovid MEDLINE, EMBASE, and Cochrane Central were systematically searched to identify eligible studies published before March 27, 2016 (...) that composite and specific phytoestrogen supplementations were associated with modest reductions in the frequency of hot flashes and vaginal dryness but no significant reduction in night sweats. However, because of general suboptimal quality and the heterogeneous nature of the current evidence, further rigorous studies are needed to determine the association of plant-based and natural therapies with menopausal health.

Full Text available with Trip Pro

2016 JAMA

64. Chinese herbal medicine for menopausal symptoms. (PubMed)

Chinese herbal medicine for menopausal symptoms. Chinese herbal medicine (CHM) usage is expected to increase as women suffering from menopausal symptoms are seeking alternative therapy due to concerns from the adverse effects (AEs) associated with hormone therapy (HT). Scientific evidence for their effectiveness and safety is needed.To evaluate the effectiveness and safety of CHM in the treatment of menopausal symptoms.We searched the Gynaecology and Fertility Group's Specialised Register (...) trials (RCTs) comparing the effectiveness of CHM with placebo, HT, pharmaceutical drugs, acupuncture, or another CHM formula in women over 18 years of age, and suffering from menopausal symptoms.Two review authors independently assessed 864 studies for eligibility. Data extractions were performed by them with disagreements resolved through group discussion and clarification of data or direct contact with the study authors. Data analyses were performed in accordance with Cochrane Collaboration

Full Text available with Trip Pro

2016 Cochrane

65. Menopause Management - Getting Clinical Care Back on Track. (PubMed)

Menopause Management - Getting Clinical Care Back on Track. 26962899 2016 03 15 2018 12 02 1533-4406 374 9 2016 Mar 03 The New England journal of medicine N. Engl. J. Med. Menopause Management--Getting Clinical Care Back on Track. 803-6 10.1056/NEJMp1514242 Manson JoAnn E JE From the Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston (J.E.M.); and the University of Florida College of Medicine, Jacksonville (A.M.K.). Kaunitz Andrew M AM From the Department (...) of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston (J.E.M.); and the University of Florida College of Medicine, Jacksonville (A.M.K.). eng Journal Article United States N Engl J Med 0255562 0028-4793 AIM IM Hormone Replacement Therapy adverse effects statistics & numerical data Humans Internal Medicine education Internship and Residency Menopause drug effects Middle Aged Risk United States Women's Health 2016 3 11 6 0 2016 3 11 6 0 2016 3 16 6 0 ppublish 26962899 10.1056

2016 NEJM

66. Acupuncture for Menopausal Hot Flashes: A Randomized Trial. (PubMed)

Acupuncture for Menopausal Hot Flashes: A Randomized Trial. Hot flashes (HFs) affect up to 75% of menopausal women and pose a considerable health and financial burden. Evidence of acupuncture efficacy as an HF treatment is conflicting.To assess the efficacy of Chinese medicine acupuncture against sham acupuncture for menopausal HFs.Stratified, blind (participants, outcome assessors, and investigators, but not treating acupuncturists), parallel, randomized, sham-controlled trial with equal (...) allocation. (Australia New Zealand Clinical Trials Registry: ACTRN12611000393954).Community in Australia.Women older than 40 years in the late menopausal transition or postmenopause with at least 7 moderate HFs daily, meeting criteria for Chinese medicine diagnosis of kidney yin deficiency.10 treatments over 8 weeks of either standardized Chinese medicine needle acupuncture designed to treat kidney yin deficiency or noninsertive sham acupuncture.The primary outcome was HF score at the end of treatment

2016 Annals of Internal Medicine

67. Managing menopausal symptoms after breast cancer - a guide for women

Managing menopausal symptoms after breast cancer - a guide for women A guide for women Managing menopausal symptoms after breast cancerManaging menopausal symptoms after breast cancer A guide for womenBreast cancer and early menopause — a guide for younger women First edition published in 2008 by: National Breast and Ovarian Cancer Centre*. Managing menopausal symptoms after breast cancer Second edition published in 2016 by Cancer Australia Locked Bag 3, Strawberry Hills NSW 2012 Tel: 61 2 9357 (...) 9400 Fax: 61 2 9357 9477 canceraustralia.gov.au © Cancer Australia 2016 ISBN Print: 978-1-74127-252-9 Online: 978-1-74127-253-6 CIP: 616.99449 Recommended citation: Cancer Australia. Managing menopausal symptoms after breast cancer. Cancer Australia, Surry Hills, NSW, 2012. Managing menopausal symptoms after breast cancer, can be downloaded or ordered from the Cancer Australia website: canceraustralia.gov.au/resources Copyright statements Paper-based publications This work is copyright. You may

2016 Cancer Australia

68. Canadian Consensus on Female Nutrition: Adolescence, Reproduction, Menopause, and Beyond

Canadian Consensus on Female Nutrition: Adolescence, Reproduction, Menopause, and Beyond Canadian Consensus on Female Nutrition: Adolescence, Reproduction, Menopause, and Beyond - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 38, Issue 6, Pages 508–554.e18 Canadian Consensus on Female Nutrition: Adolescence, Reproduction, Menopause, and Beyond Nutrition Working Group x Deborah L. O'Connor , PhD, RD (Principal Author (...) ; FSH, follicle-stimulating hormone; AMH, anti-mullerian hormone Abstract Objectives To provide health care professionals in Canada with the basic knowledge and tools to provide nutrition guidance to women through their lifecycle. Outcomes Optimal nutrition through the female lifecycle was evaluated, with specific focus on adolescence, pre-conception, pregnancy, postpartum, menopause, and beyond. The guideline begins with an overview of guidance for all women, followed by chapters that examine

2016 Society of Obstetricians and Gynaecologists of Canada

69. Menopausal hormone therapy: in addition to other risks, an increased risk of ovarian cancer

Menopausal hormone therapy: in addition to other risks, an increased risk of ovarian cancer Prescrire IN ENGLISH - Spotlight ''Menopausal hormone therapy: in addition to other risks, an increased risk of ovarian cancer'', 1 January 2016 {1} {1} {1} | | > > > Menopausal hormone therapy: in addition to other risks, an increased risk of ovarian cancer Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |    (...) |   |   |   |  Spotlight Menopausal hormone therapy: in addition to other risks, an increased risk of ovarian cancer The harm-benefit balance for hormone replacement therapy in menopause is unfavourable due to an increased risk of cardiovascular disease and of breast cancer. It also exposes women to ovarian cancer. At the beginning of 2015, a review of 52 epidemiological studies showed a statistically significant risk of ovarian cancer in women exposed to menopausal

2016 Prescrire

70. Examining the psychometric properties of the brief 'Menopausal Symptoms Distress Affecting Sleep Quality Scale' (PubMed)

Examining the psychometric properties of the brief 'Menopausal Symptoms Distress Affecting Sleep Quality Scale' To examine the psychometric properties of the Menopausal Symptoms Distress Affecting Sleep Quality Scale.Sleep disturbances are an extensive and common problem among menopausal women. However, no unique and specific scale has yet been developed to detect the inductive symptoms distresses that cause poor sleep quality for menopausal women.A cross-sectional design.The Menopausal (...) Symptoms Distress Affecting Sleep Quality Scale was based on in-depth interviews with menopausal women and literature review. Convenience sampling was employed. One hundred and fifty three women participated in this study. Exploratory factor analysis, concurrent validity and contrasting group validity were used to examine the validity of the Menopausal Symptoms Distress Affecting Sleep Quality Scale. Cronbach's α was conducted to test the reliability. The accuracy of the scale was analysed

2015 EvidenceUpdates

71. Limited Evidence Suggests Oral Health Providers Should Observe Caution When Treating Post-Menopausal Women Taking Aromatase Inhibitor (AI) Drugs or Estrogen Modulating Agents

Limited Evidence Suggests Oral Health Providers Should Observe Caution When Treating Post-Menopausal Women Taking Aromatase Inhibitor (AI) Drugs or Estrogen Modulating Agents UTCAT2949, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Limited Evidence Suggests Oral Health Providers Should Observe Caution When Treating Post-Menopausal Women Taking Aromatase Inhibitor (AI) Drugs or Estrogen Modulating Agents Clinical (...) Question Is there an increased risk of alveolar bone loss and dental-related complications in post-menopausal women taking aromatase inhibitor drugs or estrogen/progesterone modulator agents? Clinical Bottom Line Special consideration should be taken regarding the treatment of post-menopausal women taking aromatase inhibitor (AI) drugs. In particular, this includes monitoring periodontal disease, patients undergoing dentoalveolar surgery, and monitoring bone density. Evidence suggests appreciable loss

2015 UTHSCSA Dental School CAT Library

72. Periodontal treatment outcomes in post menopausal women receiving hormone replacement therapy (PubMed)

Periodontal treatment outcomes in post menopausal women receiving hormone replacement therapy To evaluate the effect of hormone replacement therapy(HRT) on periodontal treatment outcomes in a group of postmenopausal women with periodontitis.23 post-menopausal chronic periodontitis patients were included in this study. The test group(n=11) consisted of women who started HRT with this study and received conjugated estrogen and medroxyprogesteron. The control group(n=12) was women not taking any

Full Text available with Trip Pro

2015 Journal of Istanbul University Faculty of Dentistry

73. Women's experience of menopause: a systematic review of qualitative evidence. (PubMed)

Women's experience of menopause: a systematic review of qualitative evidence. Evidence shows than an estimated one billion women have experienced menopause worldwide. The experience of menopause is influenced by beliefs and values prevalent in the sociocultural setting, the background of the women, and the ways in which the women approach changes in this phase of life. Independently of the circumstances involved, women experiencing menopause need to have their care needs and corresponding (...) support identified based on their personal and contextual perspectives. Although it is essential to provide appropriate support to women experiencing menopause, no systematic reviews have so far been conducted that focus on menopause experienced by women worldwide.The objective of this review is to identify the best available evidence related to how women experience menopause worldwide.This review considered studies that included menopausal women aged between 40 and 65 years, who have lived

2015 JBI database of systematic reviews and implementation reports

74. No sex please, we’re menopausal!

No sex please, we’re menopausal! No sex please, we're menopausal! - Evidently Cochrane Search and hit Go By March 13, 2015 // In today’s guest blog, Elaine Miller, a physiotherapist who also does a stand-up comedy show about pelvic floors, tackles sex and the menopause. I have a faded post-it note on my office wall that says “what most people need is a really good listening to”. It’s sound advice for life, but, particularly useful whenever a patient brings up a sexual function issue in clinic (...) . Menopausal women often experience changes in how they think about their bodies and sexuality. Many have sad feelings about the loss of fertility and the body of their youth. Of course, some women relish not fearing unwanted pregnancy and finally feeling comfortable in their own skin. Elaine Miller, tackling the taboo with humour and reliable information. Sexuality is not just about having sex, and sex is about more than penetration. A lack of intimacy, in whatever form, negatively impacts our wellbeing

2015 Evidently Cochrane

75. Hormone Therapy for the Menopause after Endometriosis Surgery – Friend or Foe?

Hormone Therapy for the Menopause after Endometriosis Surgery – Friend or Foe? Hormone Therapy for the Menopause after Endometriosis Surgery - Friend or Foe? - Evidently Cochrane Search and hit Go By March 12, 2015 // In today’s guest blog, Dr Martin Hirsch explains about endometriosis and treatment choices for women who have the menopause induced because of it. It’s Menopause Week here at Evidently Cochrane and as a team including individual bloggers, Cochrane UK, Healthtalk and Menopause UK (...) with their NHS Change Day campaign to ‘Change the Change’, we are summarising the evidence surrounding the menopause to ensure women get the correct facts from reliable evidence. This blog aims to help women who have had the menopause induced through surgery for endometriosis make more informed health decisions at a time of significant change for their mind and body. Endometriosis – what is it and how do I know if I have it? Most women have heard of the menopause. They fear it, but for a select few women

2015 Evidently Cochrane

76. Everything I needed to know about the menopause… No One Told Me

Everything I needed to know about the menopause… No One Told Me Everything I needed to know about the menopause... No One Told Me - Evidently Cochrane Search and hit Go By March 11, 2015 // Today’s guest blog comes from Oxford academic June Girvin, who shares her experiences of the menopause, the taboo and the information gap. Today is NHS Change Day and June, along with the rest of our guest bloggers in this special series on the menopause, is backing Menopause UK’s grassroots campaign (...) for Change Day to #changethechange. You can read more about that here. It’s Menopause Week on Evidently Cochrane. I wasn’t sure whether that required an exclamation mark, but decided, all things considered, that it didn’t. My contribution to this week of menopause related blogs is a personal one – or a phenomenological one as this is a blog for ‘Evidently Cochrane’ – and I think my lived experience of the ‘last taboo’ or the ‘Big M’ (thankfully one rarely hears it called ‘THE CHANGE’ anymore with all its

2015 Evidently Cochrane

77. Let’s talk about the menopause

Let’s talk about the menopause Let's talk about the menopause - Evidently Cochrane Search and hit Go By March 6, 2015 // In the first of our series of guest blogs about the menopause and health, Jenny Hislop , a Senior Qualitative Researcher in the (HERG) at the University of Oxford, talks about her research on the menopause and collecting women’s stories for the website. The website healthtalk.org “brings the menopause into the open.” A few years ago I had the privilege of interviewing 46 (...) women throughout the UK about their experiences of the menopause for the award-winning website What impressed me most was their willingness to talk openly about the menopause and its impact on their everyday lives. And it takes courage to do this. We live in a society where we tend to build a wall of silence around personal matters like the menopause – it’s something we keep hidden and as a result no one really knows what to expect. And I think this is one of the key strengths of the menopause site

2015 Evidently Cochrane

78. Making sense of the menopause: experience, evidence and you

Making sense of the menopause: experience, evidence and you Making sense of the menopause: experience, evidence and you - Evidently Cochrane Search and hit Go By March 6, 2015 // Let’s talk about the menopause. We really need to! We’ve designated next week Menopause Week on Evidently Cochrane and this afternoon we start a series of six guest blogs on the menopause, from women brave enough to share their experiences and doctors and researchers with the latest evidence on treatments. We’re also (...) supporting in their actions for NHS Change Day on March 11th which they hope will #changethechange. It’s unthinkable that we wouldn’t tell girls about menstruation, yet this other stage in women’s lives is not freely discussed and women are arriving at it unprepared. This isn’t so in all cultures and in those where aging conveys status the menopause is often treated rather differently. Louise Foxcroft has noted, in her excellent book on the modern menopause, that modern Jewish Orthodox practice has begun

2015 Evidently Cochrane

79. Menopausal Symptoms: Comparative Effectiveness of Therapies

Menopausal Symptoms: Comparative Effectiveness of Therapies Menopausal Symptoms: Comparative Effectiveness of Therapies Comparative Effectiveness Review Number 147Comparative Effectiveness Review Number 147 Menopausal Symptoms: Comparative Effectiveness of Therapies Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract No. 290-2007-10058-I Prepared by: Blue Cross and Blue Shield (...) presented in this report. Suggested citation: Grant MD, Marbella A, Wang AT, Pines E, Hoag J, Bonnell C, Ziegler KM, Aronson N. Menopausal Symptoms: Comparative Effectiveness of Therapies. Comparative Effectiveness Review No. 147. (Prepared by Blue Cross and Blue Shield Association Technology Evaluation Center Evidence-based Practice Center under Contract No. 290-2007- 10058-I.) AHRQ Publication No. 15-EHC005-EF. Rockville, MD: Agency for Healthcare Research and Quality; March 2015

2015 Effective Health Care Program (AHRQ)

80. Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition (PubMed)

Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition The expected duration of menopausal vasomotor symptoms (VMS) is important to women making decisions about possible treatments.To determine total duration of frequent VMS (≥ 6 days in the previous 2 weeks) (hereafter total VMS duration) during the menopausal transition, to quantify how long frequent VMS persist after the final menstrual period (FMP) (hereafter post-FMP persistence), and to identify risk factors for longer (...) total VMS duration and longer post-FMP persistence.The Study of Women's Health Across the Nation (SWAN) is a multiracial/multiethnic observational study of the menopausal transition among 3302 women enrolled at 7 US sites. From February 1996 through April 2013, women completed a median of 13 visits. Analyses included 1449 women with frequent VMS.Total VMS duration (in years) (hot flashes or night sweats) and post-FMP persistence (in years) into postmenopause.The median total VMS duration was 7.4

Full Text available with Trip Pro

2015 EvidenceUpdates